ELV vs HUM
ELV and HUM side by side — valuation & fundamentals (public data).
Key statistics
| Metric | ELVElevance Health, Inc. | HUMHUMANA INC |
|---|---|---|
| Market cap | $90.75B | $49.77B |
| P/E (TTM) | 17.8 | 44.2 |
| P/B | 2.03 | 2.68 |
| P/S | 0.5x | 0.4x |
| Dividend yield | 1.68% | 0.86% |
| Revenue | $201.83B(TTM) | $137.20B(TTM) |
| Revenue growth (YoY) | 12.5% | 10.1% |
| Net income | $5.14B(TTM) | $1.13B(TTM) |
| Earnings growth (YoY) | -5.3% | -1.6% |
| EPS, diluted | $23.55(TTM) | $9.37(TTM) |
| EBIT margin | 3.6% | 2.1% |
| ROE | 12.7% | 6.4% |
| ROIC | 9.4% | 8.1% |
| 1y total return | +32.7% | +46.3% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: ELV vs HUM
| Metric | ELV | HUM |
|---|---|---|
| End value | $36.9K | $24.6K |
| Total return | +268.6% | +146.2% |
| CAGR | +13.4% | +9.1% |
| Volatility | 31.0% | 34.8% |
| Sharpe | 0.43 | 0.31 |
| Sortino | 0.61 | 0.43 |
| Max drawdown | -50.4% | -69.9% |
Based on 2600 common trading days, 2016-06-29 → 2026-10-30 · risk-free 4.16% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)